Pharmaceutical compositions for treating adrenoleukodystrophy
US5331009A · kind A · utility
1Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1989 |
| Grant date | Jul 19, 1994 |
| Priority date | — |
| Expiry date | Sep 25, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C69/533
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for the treatment of adrenoleukodystrophy comprises a mixture of erucic acid and less than 20% of C20:1, in the absence of any C24:0 and C26:0 acids (all the acids being as such or in the form of physiologically acceptable derivatives, e.g. the triglycerides). For dietary administration, the compositions are preferably mixed with a dietary supplement comprising glyeceryl trioleate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.